PROFOUND MEDICAL CORP. Shareholders' Equity
PROFOUND MEDICAL CORP. (PROF) had Shareholders' Equity of $49.81 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $49.81M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $59.42M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $66.43M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $32.14M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $49.81M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $59.42M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $66.43M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $32.14M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $39.26M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $50.79M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $60.42M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $30.72M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $38.90M 10-Q · filed 2025-11-13 |
| 2024-03-31 | $45.52M 10-Q · filed 2025-11-13 |
| 2023-12-31 | $31.22M 10-K · filed 2026-03-05 |
| 2022-12-31 | $52.60M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |